AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 MAR 28 - (NewsRx.com & NewsRx.net) --
by N.R. Saltmarsh, staff medical writer - Immunization of mice with a DNA protein protects against leprosy infection at least as well as the Mycobacterium bovis bacille Calmette-Guerin (BCG) vaccine currently in use.
Leprosy remains a worldwide problem despite vaccination with BCG, and development of new vaccines is imperative, said E. Martin and colleagues at the Centenary Institute for Cancer Medicine and Cell Biology in Washington, DC.
"The immune dominant 35 kDa protein, shared [by] Mycobacterium leprae and M. avium, but not M. tuberculosis or BCG, is recognized by >90% of leprosy patients, making it an ideal candidate antigen for a subunit vaccine," proposed Martin et al.
The researchers found that mice immunized with a DNA-35 vaccine produced T cells and IFN-gamma and were protected against M. leprae footpad infection. The DNA-35 was at least as efficacious as the BCG vaccine ("DNA encoding a single mycobacterial antigen ...